---
layout: post
title: "Animal Generic Drug User Fee Rates and Payment Procedures for Fiscal Year 2023"
date: 2026-02-05 18:59:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-16174
original_published: 2022-07-28 00:00:00 +0000
significance: 8.00
---

# Animal Generic Drug User Fee Rates and Payment Procedures for Fiscal Year 2023

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 28, 2022 00:00 UTC
**Document Number:** 2022-16174

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the fee rates and payment procedures for fiscal year (FY) 2023 generic new animal drug user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Generic Drug User Fee Amendments of 2018 (AGDUFA III), authorizes FDA to collect user fees for certain abbreviated applications for generic new animal drugs, for certain generic new animal drug products, and for certain sponsors of abbreviated applications for generic new animal drugs and/or investigational submissions for generic new animal drugs. This notice establishes the fee rates for FY 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/28/2022-16174/animal-generic-drug-user-fee-rates-and-payment-procedures-for-fiscal-year-2023)
- API: https://www.federalregister.gov/api/v1/documents/2022-16174

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
